A major focus is targeted on colorimetric detection, fluorescence, chemiluminescence, Localized Surface Plasmon Resonance, and Surface-Enhanced Raman Scattering-based optical nanobiosensor signaling readout techniques, which enable the detection of CVD biomarkers. Furthermore, this book explores emerging healthcare technologies for next-generation portable PoCT devices and recent advances in nanobiosensor techniques for the rapid detection of CVD biomarkers. One dedicated chapter explores the role of artificial intelligence in enhancing point-of-care diagnostics for CVDs, while another addresses critical regulatory challenges and safety considerations in translating nanomaterial-based biosensors into clinical practice.
Table of Contents
1. An Overview of Novel Biomarkers for Cardiovascular Disease and Advances in Point-of-Care Diagnostics2. Selection of Bioreceptors for Nanobiosensors: Fundamentals and Innovations in Point-of-Care Applications
3. Comprehensive Overview of Optical Nanomaterials: Fundamentals and Advantages of Biosensor Applications
4. Optical nanobiosensors: Design, Integration of Binding Receptors and Sensing Mechanisms
5. Optical Readout Techniques in Nanobiosensors: Fundamentals and Future Directions for Point-of-Care Applications
6. A Visible, Colorimetric Point-of-Care Nanobiosensor for the Detection of Cardiovascular Disease Biomarkers
7. Fluorescence-Based Point-of-Care Nanobiosensors for the Detection of Cardiovascular Disease Biomarkers
8. Nanomaterials-based Point-of-Care Chemiluminescence Biosensors for the Detection of Cardiovascular Disease Biomarkers
9. Localized Surface Plasmon Resonance-based Biosensor for Point-of-Care Detection of Cardiovascular Disease Biomarkers
10. Surface-Enhanced Raman Scattering-Based Nanobiosensors for Point-of-Care Detection of Cardiovascular Biomarkers
11. Emerging Healthcare Technologies for Next-Generation Portable Point-of-Care Testing Devices
12. Recent Advances in Point-of-Care Nanobiosensor Techniques for the Rapid Diagnosis of Cardiovascular Disease Biomarkers
13. The Role of Artificial Intelligence in Point-of-Care Diagnosis of Cardiovascular Diseases
14. Regulatory and Safety Considerations for Nanomaterial-Medical and Point-of-Care Diagnostic Devices
15. Nanomaterial-Based Point-of-Care Testing Devices for Cardiovascular Disease Biomarker: Advancing Technologies Toward Clinical Translation
Authors
Tharmaraj Vairaperumal Institute of Clinical Medicine, National Cheng Kung University, Taiwan.Dr. Tharmaraj Vairaperumal, Postdoctoral Research Scientist at Institute of Clinical Medicine, National Cheng Kung University, Taiwan. His research expertise involves the development of advanced point-of-care testing technologies, focusing on portable microfluidic devices integrated with nanobiosensors for cardiovascular diagnostics.
Devi Selvaraj Assistant Professor in the P.G. and Research Department of Chemistry at Cauvery College for Women, India.Dr. Devi Selvaraj, Assistant Professor in the P.G. and Research Department of Chemistry at Cauvery College for Women, India. Her research focuses on the design and development of nanomaterial-based electrochemical biosensors for point-of-care testing applications.
Ping-Yen Liu Director of Internal Medicine at the National Cheng Kung University Hospital in Tainan, Taiwan.Prof. Ping-Yen Liu, Director of Internal Medicine at National Cheng Kung University Hospital, and Affiliated Distinguished Professor at Division of Cardiology, Institute of Clinical Medicine, National Cheng Kung University, Taiwan. His research focuses on developing nanobiosensor-based PoCT technologies for cardiovascular diagnostics.
